Prognos
Mike Coyne is currently an advisor at Prognos, but they have held many other high-level positions in the past. Mike was the CEO of Lux Research from August 2016 to August 2019, during which time they successfully led the company's sale to a private equity firm. Mike also served on the board of Equian from January 2016 to July 2019. Prior to that, they were the CEO of Quantia Inc. from August 2012 to July 2015. There, they established the company as a leading provider of digital physician engagement solutions and oversaw its acquisition by Merck's Physicians Interactive division. From November 2004 to July 2012, Coyne was the CEO, President, and Executive Vice President of Verisk Health. And before that, they were Verisk's Business Development Manager from February 2001 to November 2005.
Mike Coyne has a BA from the College of the Holy Cross, an MBA from Fordham University, and a JD from St. John's University School of Law. Mike also went to Malvern Prep.
This person is not in the org chart
This person is not in any offices
Prognos
7 followers
Prognos® Health is a patient-centric data and analytics company that harnesses the value of real-world data (RWD) to accelerate the path to clinical truth.